Science and Technology
When will Intellia Therapeutics submit a BLA for Lonvo-z?
Lonvoguran Ziclumeran (lonvo-z) - BLA
Markets
before April 2027
80%
before 2027
75%
before December
71%
Rules
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Outcome verified from Food and Drug Administration.
Additional prohibitions
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.
Legal
By trading on this market, you agree to the Trading prohibitions, Member agreement, and DFlow terms of service.